Faraizah Abdul Karim

Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial

Peter W. Collins, Guy Young, Karin Knobe et al. · Blood · 2014 · 180 citations · Full text

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim et al. · Blood · 2016 · 85 citations · Full text

Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

Steven R. Lentz, S. Ehrenforth, Faraizah Abdul Karim et al. · Journal of Thrombosis and Haemostasis · 2014 · 67 citations · Full text

Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity

Johnny Mahlangu, Karin Weldingh, Steven R. Lentz et al. · Journal of Thrombosis and Haemostasis · 2015 · 59 citations · Full text

Clinical Immunology, Molecular Immunology, Immunogenetics +9

Nonacog beta pegol (N9-GP) in haemophilia B: A multinational phase III safety and efficacy extension trial (paradigm™4)

Guy Young, Peter W. Collins, T. Colberg et al. · Thrombosis Research · 2016 · 58 citations

Allergy, Medicine, Hematology +4